Clinical Trial Update: M1 Schizophrenia PET Study [Phase 1]

View source ↗

Summary

A Phase 1 PET imaging study (M1) at Yale University investigating schizophrenia and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Yale University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED